despite a strong pharmacologic rationale and a vast clinical experience , hdmtx with leucovorin rescue has not been shown to be unequivocally superior to conventional doses of mtx in any clinical situation except , perhaps , for treatment of osteogenic sarcoma and childhood acute leukemia .
C0025677
hdmtx
C0029463
osteogenic sarcoma